231 related articles for article (PubMed ID: 17990233)
1. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.
Ramadhani HO; Thielman NM; Landman KZ; Ndosi EM; Gao F; Kirchherr JL; Shah R; Shao HJ; Morpeth SC; McNeill JD; Shao JF; Bartlett JA; Crump JA
Clin Infect Dis; 2007 Dec; 45(11):1492-8. PubMed ID: 17990233
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
[TBL] [Abstract][Full Text] [Related]
4. High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania - A prospective cohort study.
Bircher RE; Ntamatungiro AJ; Glass TR; Mnzava D; Nyuri A; Mapesi H; Paris DH; Battegay M; Klimkait T; Weisser M;
PLoS One; 2020; 15(1):e0227600. PubMed ID: 31929566
[TBL] [Abstract][Full Text] [Related]
5. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
[TBL] [Abstract][Full Text] [Related]
6. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
[TBL] [Abstract][Full Text] [Related]
7. Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up.
Dow DE; Shayo AM; Cunningham CK; Reddy EA
BMC Infect Dis; 2014 Nov; 14():567. PubMed ID: 25373425
[TBL] [Abstract][Full Text] [Related]
8. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
[TBL] [Abstract][Full Text] [Related]
9. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.
Maggiolo F; Ravasio L; Ripamonti D; Gregis G; Quinzan G; Arici C; Airoldi M; Suter F
Clin Infect Dis; 2005 Jan; 40(1):158-63. PubMed ID: 15614706
[TBL] [Abstract][Full Text] [Related]
10. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
11. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
Jean Louis F; Buteau J; François K; Hulland E; Domerçant JW; Yang C; Boncy J; Burris R; Pelletier V; Wagar N; Deyde V; Lowrance DW; Charles M
PLoS One; 2018; 13(1):e0192077. PubMed ID: 29381736
[TBL] [Abstract][Full Text] [Related]
12. Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis.
Mantshonyane L; Roy J; Levy MZ; Wallis CL; Bar K; Godfrey C; Collier A; LaRosa A; Zheng L; Sun X; Gross R
AIDS Patient Care STDS; 2021 Dec; 35(12):467-473. PubMed ID: 34788110
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictive value of intermittent viremia with combination hiv therapy.
Havlir DV; Bassett R; Levitan D; Gilbert P; Tebas P; Collier AC; Hirsch MS; Ignacio C; Condra J; Günthard HF; Richman DD; Wong JK
JAMA; 2001 Jul; 286(2):171-9. PubMed ID: 11448280
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
Tabb ZJ; Mmbaga BT; Gandhi M; Louie A; Kuncze K; Okochi H; Shayo AM; Turner EL; Cunningham CK; Dow DE
AIDS; 2018 Jun; 32(9):1115-1123. PubMed ID: 29438196
[TBL] [Abstract][Full Text] [Related]
15. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.
Swindells S; DiRienzo AG; Wilkin T; Fletcher CV; Margolis DM; Thal GD; Godfrey C; Bastow B; Ray MG; Wang H; Coombs RW; McKinnon J; Mellors JW;
JAMA; 2006 Aug; 296(7):806-14. PubMed ID: 16905786
[TBL] [Abstract][Full Text] [Related]
16. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
[TBL] [Abstract][Full Text] [Related]
17. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa.
El-Khatib Z; Katzenstein D; Marrone G; Laher F; Mohapi L; Petzold M; Morris L; Ekström AM
PLoS One; 2011 Mar; 6(3):e17518. PubMed ID: 21408071
[TBL] [Abstract][Full Text] [Related]
18. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India.
Shah B; Walshe L; Saple DG; Mehta SH; Ramnani JP; Kharkar RD; Bollinger RC; Gupta A
Clin Infect Dis; 2007 May; 44(9):1235-44. PubMed ID: 17407045
[TBL] [Abstract][Full Text] [Related]
19. Adherence is not a barrier to successful antiretroviral therapy in South Africa.
Orrell C; Bangsberg DR; Badri M; Wood R
AIDS; 2003 Jun; 17(9):1369-75. PubMed ID: 12799558
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
